Researchers investigate the relationship between myopathy and intolera...Inflammatory myopathies are immunological diseases that lead to in...Inflammatory myopathies are inflammatory infiltrates in the muscle...The research team observed that it is not a rare occurrence for va...Researchers at the Teaching Unit at the UAB's Vall d'Hebron Hospit...

Researchers investigate the relationship between myopathy and intolerance to gluten.//

Inflammatory myopathies are immunological diseases that lead to inflammations in muscular tissue. Coeliac disease is occasionally reported in patients with inflammatory myopathies.

Inflammatory myopathies are inflammatory infiltrates in the muscle. This group of diseases includes polymyositis, dermatomyositis, and inclusion-body myositis. Little is known about the cause and the etiopathogenic mechanisms of these myopathies, but it is believed to be an abnormal immune response by our bodies, which identify body parts as alien. In this particular case, the body parts are the skin and the muscle, though other parts, such as the lungs and the myocardium, may also be affected.

The research team observed that it is not a rare occurrence for various autoimmune diseases to exist in the same patient. Indeed, coeliac disease -- caused by a reaction to gluten found in cereals -- has been reported in patients with inflammatory myopathy, especially those with inclusion-body myositis.

Researchers at the Teaching Unit at the UAB's Vall d'Hebron Hospital have investigated these links by looking at coeliac patients whose cases suggest a similar immunopathogenic mechanism in coeliac disease and certain myopathies, as well as a common genetic substrate.

The scientists are considering the possibility that, at least in part, some inflammatory myopathies are a clinical expression of intolerance to gluten, though they point out the need for more studies to be carried out to confirm or support these findings. The results are particularly important in the case of inclusion-body myositis -- for which there is no effective treatment -- since we can now suggest that a gluten-free diet may improve the situation of a patient. This hypothesis must now be tested using immunosuppressants, as has been done with other extraintestinal manifestations of reac
tions to gluten.

(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...

(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...

(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...

(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...

(Date:12/8/2016)... , Dec. 8, 2016 Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...

(Date:12/8/2016)... Pa. , Dec. 8, 2016 Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...